ABLA describes bleeding which results in a decrease number of RBCs, meaning the production of new red blood cells in the body cannot keep up with the loss of RBCs through bleeding. The indicators used to apply ABLA to a surgical patient would be that same whether this medication was given or not.
MSN: Don't want people to see me as Abla Naari or know me for my appearance: Smriti Irani at WITT Summit
Don't want people to see me as Abla Naari or know me for my appearance: Smriti Irani at WITT Summit
Agreed. And for postoperative blood loss anemia, you don't even need the word "acute" to code D62, ABLA. The word acute is a non-essential modifier in code description, "Postopeartive anemia due to (acute) blood loss" since it's in parentheses ().
For surgical patients I typically look fro ABLA on the 2nd day post-op to account for fluid shifts and allow the pateint to stabilize post surgery. For open hearts, I give them another day and assess on post-op day 3.
Also, think about those patients that surely have ABLA, but refuse Transfusion. Think about: Additional Evaluation & Monitoring, More Frequent Vitals, iron supplements.
I've read many articles regarding physicians documentation of ABLA following a woman's delivery. It's a bit confusing as there are differing opinions.
I believe ABLA is considered a complication of care regardless of the numeric designation of 285.1 vs. 997/998 codes. Without transfusion, I believe you will find them to be universally resistant to documenting ABLA.